GAMBACORTI PASSERINI CARLO

Position:
Role
Full Professor  
Academic disciplines
Blood Diseases (MEDS-09/B)
Scientific-Disciplinary Group:
BLOOD DISEASES, ONCOLOGY AND RHEUMATOLOGY (06/MEDS-09)
Office phone
Room:
  • U08, Floor: 4, Room: 4-12
  • U08, Floor: 4, Room: 4041

Publications

  • Kogan, M., Alviano, A., Catalano, M., Casiraghi, A., Ghilardi, G., Rindone, G., et al. (2025). Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient. AIDS RESEARCH AND THERAPY, 22(1) [10.1186/s12981-025-00717-9]. Detail

  • Manghisi, B., Cotilli, G., Fedele, M., Perfetti, P., Terruzzi, E., Verga, L., et al. (2025). Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy. FRONTIERS IN IMMUNOLOGY, 16 [10.3389/fimmu.2025.1563736]. Detail

  • Civettini, I., Zappaterra, A., Corti, P., Messina, A., Aroldi, A., Biondi, A., et al. (2025). Hb Monza: A novel extensive HBB duplication with preserved α-β subunit interaction and unstable hemoglobin phenotype. MED, 6(4) [10.1016/j.medj.2024.11.007]. Detail

  • Crippa, V., Fontana, D., Civettini, I., Mologni, L., Piazza, R., Gambacorti Passerini, C., et al. (2024). Integrating mutational profiles and transcriptional data with ASTUTE to elucidate the key molecular functions involved in the pathogenesis of cancer. Intervento presentato a: AACR Annual Meeting 2024 - April 5 - 10, 2024, San Diego, Ca, Usa. Detail

  • Fontana, D., Malighetti, F., Villa, M., Zambon, A., Gambacorti-Passerini, C., Mologni, L. (2024). Repurposing pexmetinib as an inhibitor of TKI-resistant BCR::ABL1. LEUKEMIA, 38(8), 1843-1847 [10.1038/S41375-024-02282-Y]. Detail

Research projects

Bioinformatic integration of clonal hierarchies, mutational and functional landscapes of tumors to build a theragnostic tool in cancer treatment
Year: 2021
Call: FAQC 2021 - terza finestra
Grantors: Università degli Studi di MILANO-BICOCCA
FANTOM - Future of ALCL: Novel Therapies, Origins, Bio-Markers and Mechanism of resistance
Year: 2021
Call: MSCA Doctoral Networks 2021
Grantors: EUROPEAN COMMISSION
Molecular pathogenesis of atypical CML: Converting NGS-obtained data into therapeutically relevant information - V annualità
Year: 2021
Call: 2017-005 - Call for Proposals 2017 Investigator Grant (IG)
Grantors: FONDAZIONE AIRC
Molecular pathogenesis of atypical CML: Converting NGS-obtained data into therapeutically relevant information - IV annualità
Year: 2020
Call: 2017-005 - Call for Proposals 2017 Investigator Grant (IG)
Grantors: FONDAZIONE AIRC
HARMONY PLUS-Clonal hierarchy in CML
Year: 2019
Call: Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
Grantors: EUROPEAN COMMISSION

Awards

Awards

  • ABILITAZIONE SCIENTIFICA NAZIONALE A PROFESSORE DI I FASCIA, SSD MED015, MIUR, 2013

Research and teaching assignments

  • Professore a contratto - Professor of Oncology and hematology, Canada research Chair, Dept of Oncology, Jewish General Hospital, Montreal, Canadà - McGill University, 2003 - 2008

Congresses/Conferences

  • Program chair - 5th ERIA meeting, "20 year of anniversary of the discovery of ALK", 2014